APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epoprostenol Sodium Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Epoprostenol Sodium Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025191 pages

Choose your research edition.

Industry ResearchEpoprostenol Sodium Drugs Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Epoprostenol Sodium Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Epoprostenol Sodium Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epoprostenol Sodium Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Epoprostenol Sodium Drugs Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Epoprostenol Sodium Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Epoprostenol Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Epoprostenol Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Epoprostenol Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Epoprostenol Sodium Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Epoprostenol Sodium Drugs include GSK, Teva, Sun Pharmaceutical, Johnson & Johnson, Novartis, PanPharmaceuticals, Nichiiko, Laboratorios Normon and LAB UNKNOWN, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Epoprostenol Sodium Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Epoprostenol Sodium Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Epoprostenol Sodium Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Epoprostenol Sodium Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Epoprostenol Sodium Drugs Segment by Company

GSK

Teva

Sun Pharmaceutical

Johnson & Johnson

Novartis

PanPharmaceuticals

Nichiiko

Laboratorios Normon

LAB UNKNOWN

Fuji Seiyaku Kogyo KK

DREHM Pharma

Campus Pharma

Advanz Pharma Corp

Epoprostenol Sodium Drugs Segment by Type

0.5 mg/Vail

1.5 mg/Vail

Epoprostenol Sodium Drugs Segment by Application

Hospital

Clinic

Epoprostenol Sodium Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epoprostenol Sodium Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epoprostenol Sodium Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epoprostenol Sodium Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Epoprostenol Sodium Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Epoprostenol Sodium Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Epoprostenol Sodium Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Epoprostenol Sodium Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Epoprostenol Sodium Drugs Industry Trends Table 2. Epoprostenol Sodium Drugs Industry Drivers Table 3. Epoprostenol Sodium Drugs Industry Opportunities and Challenges Table 4. Epoprostenol Sodium Drugs Industry Restraints Table 5. Global Epoprostenol Sodium Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Epoprostenol Sodium Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Epoprostenol Sodium Drugs Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Epoprostenol Sodium Drugs Sales Market Share by Manufacturers Table 9. Global Epoprostenol Sodium Drugs Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Epoprostenol Sodium Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Epoprostenol Sodium Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Epoprostenol Sodium Drugs Manufacturers, Product Type & Application Table 13. Global Epoprostenol Sodium Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Epoprostenol Sodium Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 0.5 mg/Vail Table 17. Major Manufacturers of 1.5 mg/Vail Table 18. Global Epoprostenol Sodium Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Epoprostenol Sodium Drugs Sales by Type (2021-2026) & (k units) Table 20. Global Epoprostenol Sodium Drugs Sales by Type (2027-2032) & (k units) Table 21. Global Epoprostenol Sodium Drugs Sales Market Share by Type (2021-2026) Table 22. Global Epoprostenol Sodium Drugs Sales Market Share by Type (2027-2032) Table 23. Global Epoprostenol Sodium Drugs Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Epoprostenol Sodium Drugs Revenue by Type (2021-2026) & (k units) Table 25. Global Epoprostenol Sodium Drugs Revenue by Type (2027-2032) & (k units) Table 26. Global Epoprostenol Sodium Drugs Revenue Market Share by Type (2021-2026) Table 27. Global Epoprostenol Sodium Drugs Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Clinic Table 30. Global Epoprostenol Sodium Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 31. Global Epoprostenol Sodium Drugs Sales by Application (2021-2026) & (k units) Table 32. Global Epoprostenol Sodium Drugs Sales by Application (2027-2032) & (k units) Table 33. Global Epoprostenol Sodium Drugs Sales Market Share by Application (2021-2026) Table 34. Global Epoprostenol Sodium Drugs Sales Market Share by Application (2027-2032) Table 35. Global Epoprostenol Sodium Drugs Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Epoprostenol Sodium Drugs Revenue by Application (2021-2026) & (k units) Table 37. Global Epoprostenol Sodium Drugs Revenue by Application (2027-2032) & (k units) Table 38. Global Epoprostenol Sodium Drugs Revenue Market Share by Application (2021-2026) Table 39. Global Epoprostenol Sodium Drugs Revenue Market Share by Application (2027-2032) Table 40. Global Epoprostenol Sodium Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 41. Global Epoprostenol Sodium Drugs Sales by Region (2021-2026) & (k units) Table 42. Global Epoprostenol Sodium Drugs Sales Market Share by Region (2021-2026) Table 43. Global Epoprostenol Sodium Drugs Sales Forecasted by Region (2027-2032) & (k units) Table 44. Global Epoprostenol Sodium Drugs Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Epoprostenol Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 46. North America Epoprostenol Sodium Drugs Sales by Country (2021-2026) & (k units) Table 47. North America Epoprostenol Sodium Drugs Sales by Country (2027-2032) & (k units) Table 48. Europe Epoprostenol Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. Europe Epoprostenol Sodium Drugs Sales by Country (2021-2026) & (k units) Table 50. Europe Epoprostenol Sodium Drugs Sales by Country (2027-2032) & (k units) Table 51. Asia Pacific Epoprostenol Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Asia Pacific Epoprostenol Sodium Drugs Sales by Country (2021-2026) & (k units) Table 53. Asia Pacific Epoprostenol Sodium Drugs Sales by Country (2027-2032) & (k units) Table 54. South America, Middle East and Africa Epoprostenol Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. South America, Middle East and Africa Epoprostenol Sodium Drugs Sales by Country (2021-2026) & (k units) Table 56. South America, Middle East and Africa Epoprostenol Sodium Drugs Sales by Country (2027-2032) & (k units) Table 57. Global Epoprostenol Sodium Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Epoprostenol Sodium Drugs Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Epoprostenol Sodium Drugs Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Epoprostenol Sodium Drugs Revenue Market Share by Region (2021-2026) Table 61. Global Epoprostenol Sodium Drugs Revenue Market Share by Region (2027-2032) Table 62. GSK Company Information Table 63. GSK Business Overview Table 64. GSK Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. GSK Epoprostenol Sodium Drugs Product Portfolio Table 66. GSK Recent Development Table 67. Teva Company Information Table 68. Teva Business Overview Table 69. Teva Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Teva Epoprostenol Sodium Drugs Product Portfolio Table 71. Teva Recent Development Table 72. Sun Pharmaceutical Company Information Table 73. Sun Pharmaceutical Business Overview Table 74. Sun Pharmaceutical Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Sun Pharmaceutical Epoprostenol Sodium Drugs Product Portfolio Table 76. Sun Pharmaceutical Recent Development Table 77. Johnson & Johnson Company Information Table 78. Johnson & Johnson Business Overview Table 79. Johnson & Johnson Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Epoprostenol Sodium Drugs Product Portfolio Table 81. Johnson & Johnson Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Novartis Epoprostenol Sodium Drugs Product Portfolio Table 86. Novartis Recent Development Table 87. PanPharmaceuticals Company Information Table 88. PanPharmaceuticals Business Overview Table 89. PanPharmaceuticals Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. PanPharmaceuticals Epoprostenol Sodium Drugs Product Portfolio Table 91. PanPharmaceuticals Recent Development Table 92. Nichiiko Company Information Table 93. Nichiiko Business Overview Table 94. Nichiiko Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Nichiiko Epoprostenol Sodium Drugs Product Portfolio Table 96. Nichiiko Recent Development Table 97. Laboratorios Normon Company Information Table 98. Laboratorios Normon Business Overview Table 99. Laboratorios Normon Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Laboratorios Normon Epoprostenol Sodium Drugs Product Portfolio Table 101. Laboratorios Normon Recent Development Table 102. LAB UNKNOWN Company Information Table 103. LAB UNKNOWN Business Overview Table 104. LAB UNKNOWN Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. LAB UNKNOWN Epoprostenol Sodium Drugs Product Portfolio Table 106. LAB UNKNOWN Recent Development Table 107. Fuji Seiyaku Kogyo KK Company Information Table 108. Fuji Seiyaku Kogyo KK Business Overview Table 109. Fuji Seiyaku Kogyo KK Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Fuji Seiyaku Kogyo KK Epoprostenol Sodium Drugs Product Portfolio Table 111. Fuji Seiyaku Kogyo KK Recent Development Table 112. DREHM Pharma Company Information Table 113. DREHM Pharma Business Overview Table 114. DREHM Pharma Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. DREHM Pharma Epoprostenol Sodium Drugs Product Portfolio Table 116. DREHM Pharma Recent Development Table 117. Campus Pharma Company Information Table 118. Campus Pharma Business Overview Table 119. Campus Pharma Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Campus Pharma Epoprostenol Sodium Drugs Product Portfolio Table 121. Campus Pharma Recent Development Table 122. Advanz Pharma Corp Company Information Table 123. Advanz Pharma Corp Business Overview Table 124. Advanz Pharma Corp Epoprostenol Sodium Drugs Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Advanz Pharma Corp Epoprostenol Sodium Drugs Product Portfolio Table 126. Advanz Pharma Corp Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Epoprostenol Sodium Drugs Distributors List Table 130. Epoprostenol Sodium Drugs Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Epoprostenol Sodium Drugs Product Image Figure 2. Global Epoprostenol Sodium Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epoprostenol Sodium Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Epoprostenol Sodium Drugs Sales (2021-2032) & (k units) Figure 5. Global Epoprostenol Sodium Drugs Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Epoprostenol Sodium Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 0.5 mg/Vail Image Figure 9. 1.5 mg/Vail Image Figure 10. Global Epoprostenol Sodium Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Epoprostenol Sodium Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Epoprostenol Sodium Drugs Sales Market Share by Type (2021-2032) Figure 13. Global Epoprostenol Sodium Drugs Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Epoprostenol Sodium Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Epoprostenol Sodium Drugs Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Clinic Image Figure 18. Global Epoprostenol Sodium Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 19. Global Epoprostenol Sodium Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Epoprostenol Sodium Drugs Sales Market Share by Application (2021-2032) Figure 21. Global Epoprostenol Sodium Drugs Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Epoprostenol Sodium Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Epoprostenol Sodium Drugs Revenue Market Share by Application (2021-2032) Figure 24. North America Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 25. North America Epoprostenol Sodium Drugs Sales Market Share by Country (2021-2032) Figure 26. U.S. Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 27. Canada Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 28. Mexico Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 29. Europe Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Epoprostenol Sodium Drugs Sales Market Share by Country (2021-2032) Figure 31. Germany Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 32. France Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 33. U.K. Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 34. Italy Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 35. Netherlands Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 36. Asia Pacific Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Epoprostenol Sodium Drugs Sales Market Share by Country (2021-2032) Figure 38. China Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 39. Japan Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 40. South Korea Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 41. Southeast Asia Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 42. India Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 43. Australia Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 44. South America, Middle East and Africa Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Epoprostenol Sodium Drugs Sales Market Share by Country (2021-2032) Figure 46. Brazil Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 47. South Africa Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 48. Saudi Arabia Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 49. Turkey Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 50. Argentina Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 51. UAE Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 52. Egypt Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 53. Chile Epoprostenol Sodium Drugs Sales and Growth Rate (2021-2032) & (k units) Figure 54. Global Epoprostenol Sodium Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Epoprostenol Sodium Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Epoprostenol Sodium Drugs Revenue (2021-2032) & (US$ Million) Figure 57. North America Epoprostenol Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Epoprostenol Sodium Drugs Revenue (2021-2032) & (US$ Million) Figure 59. Europe Epoprostenol Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Epoprostenol Sodium Drugs Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Epoprostenol Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Epoprostenol Sodium Drugs Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Epoprostenol Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Epoprostenol Sodium Drugs Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Epoprostenol Sodium Drugs Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5 mg/Vail
  • 1.5 mg/Vail
Applications
  • Hospital
  • Clinic
Companies covered
  • GSK
  • Teva
  • Sun Pharmaceutical
  • Johnson & Johnson
  • Novartis
  • PanPharmaceuticals
  • Nichiiko
  • Laboratorios Normon
  • LAB UNKNOWN
  • Fuji Seiyaku Kogyo KK
  • DREHM Pharma
  • Campus Pharma
  • Advanz Pharma Corp

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Epoprostenol Sodium Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Epoprostenol Sodium Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Epoprostenol Sodium Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Epoprostenol Sodium Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Epoprostenol Sodium Drugs Market Dynamics
  1. 2.1 Epoprostenol Sodium Drugs Industry Trends
  2. 2.2 Epoprostenol Sodium Drugs Industry Drivers
  3. 2.3 Epoprostenol Sodium Drugs Industry Opportunities and Challenges
  4. 2.4 Epoprostenol Sodium Drugs Industry Restraints
3 Epoprostenol Sodium Drugs Market by Manufacturers
  1. 3.1 Global Epoprostenol Sodium Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Epoprostenol Sodium Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Epoprostenol Sodium Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Epoprostenol Sodium Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Epoprostenol Sodium Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Epoprostenol Sodium Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Epoprostenol Sodium Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Epoprostenol Sodium Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Epoprostenol Sodium Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Epoprostenol Sodium Drugs Tier 1, Tier 2, and Tier 3
4 Epoprostenol Sodium Drugs Market by Type
  1. 4.1 Epoprostenol Sodium Drugs Type Introduction
  2. 4.1.1 0.5 mg/Vail
  3. 4.1.2 1.5 mg/Vail
  4. 4.2 Global Epoprostenol Sodium Drugs Sales by Type
  5. 4.2.1 Global Epoprostenol Sodium Drugs Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Epoprostenol Sodium Drugs Sales by Type (2021-2032)
  7. 4.2.3 Global Epoprostenol Sodium Drugs Sales Market Share by Type (2021-2032)
  8. 4.3 Global Epoprostenol Sodium Drugs Revenue by Type
  9. 4.3.1 Global Epoprostenol Sodium Drugs Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Epoprostenol Sodium Drugs Revenue by Type (2021-2032)
  11. 4.3.3 Global Epoprostenol Sodium Drugs Revenue Market Share by Type (2021-2032)
5 Epoprostenol Sodium Drugs Market by Application
  1. 5.1 Epoprostenol Sodium Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Epoprostenol Sodium Drugs Sales by Application
  5. 5.2.1 Global Epoprostenol Sodium Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Epoprostenol Sodium Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global Epoprostenol Sodium Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Epoprostenol Sodium Drugs Revenue by Application
  9. 5.3.1 Global Epoprostenol Sodium Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Epoprostenol Sodium Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global Epoprostenol Sodium Drugs Revenue Market Share by Application (2021-2032)
6 Global Epoprostenol Sodium Drugs Sales by Region
  1. 6.1 Global Epoprostenol Sodium Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Epoprostenol Sodium Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Epoprostenol Sodium Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Epoprostenol Sodium Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Epoprostenol Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Epoprostenol Sodium Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Epoprostenol Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Epoprostenol Sodium Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Epoprostenol Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Epoprostenol Sodium Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Epoprostenol Sodium Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Epoprostenol Sodium Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Epoprostenol Sodium Drugs Revenue by Region
  1. 7.1 Global Epoprostenol Sodium Drugs Revenue by Region
  2. 7.1.1 Global Epoprostenol Sodium Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Epoprostenol Sodium Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Epoprostenol Sodium Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Epoprostenol Sodium Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Epoprostenol Sodium Drugs Revenue (2021-2032)
  8. 7.2.2 North America Epoprostenol Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Epoprostenol Sodium Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Epoprostenol Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Epoprostenol Sodium Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Epoprostenol Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Epoprostenol Sodium Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Epoprostenol Sodium Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 GSK
  2. 8.1.1 GSK Company Information
  3. 8.1.2 GSK Business Overview
  4. 8.1.3 GSK Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 GSK Epoprostenol Sodium Drugs Product Portfolio
  6. 8.1.5 GSK Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Epoprostenol Sodium Drugs Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Epoprostenol Sodium Drugs Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Epoprostenol Sodium Drugs Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Epoprostenol Sodium Drugs Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 PanPharmaceuticals
  32. 8.6.1 PanPharmaceuticals Company Information
  33. 8.6.2 PanPharmaceuticals Business Overview
  34. 8.6.3 PanPharmaceuticals Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PanPharmaceuticals Epoprostenol Sodium Drugs Product Portfolio
  36. 8.6.5 PanPharmaceuticals Recent Developments
  37. 8.7 Nichiiko
  38. 8.7.1 Nichiiko Company Information
  39. 8.7.2 Nichiiko Business Overview
  40. 8.7.3 Nichiiko Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nichiiko Epoprostenol Sodium Drugs Product Portfolio
  42. 8.7.5 Nichiiko Recent Developments
  43. 8.8 Laboratorios Normon
  44. 8.8.1 Laboratorios Normon Company Information
  45. 8.8.2 Laboratorios Normon Business Overview
  46. 8.8.3 Laboratorios Normon Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Laboratorios Normon Epoprostenol Sodium Drugs Product Portfolio
  48. 8.8.5 Laboratorios Normon Recent Developments
  49. 8.9 LAB UNKNOWN
  50. 8.9.1 LAB UNKNOWN Company Information
  51. 8.9.2 LAB UNKNOWN Business Overview
  52. 8.9.3 LAB UNKNOWN Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 LAB UNKNOWN Epoprostenol Sodium Drugs Product Portfolio
  54. 8.9.5 LAB UNKNOWN Recent Developments
  55. 8.10 Fuji Seiyaku Kogyo KK
  56. 8.10.1 Fuji Seiyaku Kogyo KK Company Information
  57. 8.10.2 Fuji Seiyaku Kogyo KK Business Overview
  58. 8.10.3 Fuji Seiyaku Kogyo KK Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Fuji Seiyaku Kogyo KK Epoprostenol Sodium Drugs Product Portfolio
  60. 8.10.5 Fuji Seiyaku Kogyo KK Recent Developments
  61. 8.11 DREHM Pharma
  62. 8.11.1 DREHM Pharma Company Information
  63. 8.11.2 DREHM Pharma Business Overview
  64. 8.11.3 DREHM Pharma Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 DREHM Pharma Epoprostenol Sodium Drugs Product Portfolio
  66. 8.11.5 DREHM Pharma Recent Developments
  67. 8.12 Campus Pharma
  68. 8.12.1 Campus Pharma Company Information
  69. 8.12.2 Campus Pharma Business Overview
  70. 8.12.3 Campus Pharma Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Campus Pharma Epoprostenol Sodium Drugs Product Portfolio
  72. 8.12.5 Campus Pharma Recent Developments
  73. 8.13 Advanz Pharma Corp
  74. 8.13.1 Advanz Pharma Corp Company Information
  75. 8.13.2 Advanz Pharma Corp Business Overview
  76. 8.13.3 Advanz Pharma Corp Epoprostenol Sodium Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Advanz Pharma Corp Epoprostenol Sodium Drugs Product Portfolio
  78. 8.13.5 Advanz Pharma Corp Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Epoprostenol Sodium Drugs Value Chain Analysis
  2. 9.1.1 Epoprostenol Sodium Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Epoprostenol Sodium Drugs Production Mode & Process
  6. 9.2 Epoprostenol Sodium Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Epoprostenol Sodium Drugs Distributors
  9. 9.2.3 Epoprostenol Sodium Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst